CHRISTUS SPOHN HOSPITAL BEEVILLE
Beeville, TX · CCN 450082 · Rates published
791,013 of 1,025,784 rate rows are consumer-grade (77.1%)
234,771 rows are marked excluded from the consumer medians — these stay visible in the raw drill-down with the same reason shown here, so nothing is silently hidden.
| Excluded — reason | Rows |
|---|---|
| no usable negotiated amount (only an out-of-band fallback) — excluded from medians | 224,538 |
| per-diem day rate — not a per-procedure price | 9,306 |
| template filing: same amount across many unrelated codes — excluded | 814 |
| placeholder amount (≤ $0.02) — excluded from medians | 113 |
| Source MRF file | https://www.christushealth.org/-/media/christus-health/plan-care/files/bill-pay/machine-readable-files/741109836_spohnhospitalbeeville_standardcharges.json |
|---|---|
| Found on page | https://www.christushealth.org/plan-care/bill-pay/pricing-transparency |
| Discovered via | Discovered by HANK |
| Last fetch | not_modified · 2026-05-15 |
| Content fingerprint | 78561c1cb884d1c0… · 210,563,589 bytes · first seen 2026-05-06 |
Top 50 most expensive offerings
Outliers are flagged where this hospital's filed rate is ≥2× or ≤0.5× the national median for the same code.
| Code | Description | Payers | Min $ | Max $ | Avg median | vs national |
|---|---|---|---|---|---|---|
|
J1414 HCPCS |
Injection, Fidanacogene Elaparvovec-dzkt, Per Therapeutic Dose | 21 | $3,710,000.00 | $4,130,272.28 | $3,754,792.98 |
nat. median $3,710,000 1.0× median |
|
J1411 HCPCS |
Inj, Hemgenix, Per Tx Dose | 21 | $3,685,266.67 | $4,130,272.28 | $3,754,792.98 |
nat. median $3,710,000 1.0× median |
|
J3399 HCPCS |
Inj Onase Abepar-xioi Treat | 36 | $2,423,131.23 | $4,864,954.20 | $3,644,042.71 |
nat. median $2,468,984 1.5× median |
|
J3392 HCPCS |
Injection, Exagamglogene Autotemcel, Per Treatment | 36 | $2,332,000.00 | $4,720,311.18 | $3,526,155.59 |
nat. median $2,448,600 1.4× median |
|
J1413 HCPCS |
Inj Delandistrogene Mox Rokl | 21 | $3,322,473.30 | $4,706,642.22 | $3,361,887.30 |
nat. median $3,325,455 1.0× median |
|
J3394 HCPCS |
Injection, Lovotibeglogene Autotemcel, Per Treatment | 21 | $3,231,550.94 | $4,524,171.32 | $3,231,550.94 |
nat. median $3,286,000 1.0× median |
|
J3393 HCPCS |
Injection, Betibeglogene Autotemcel, Per Treatment | 21 | $2,948,213.33 | $4,205,368.15 | $3,003,834.39 |
nat. median $3,004,655 1.0× median |
|
Q2056 HCPCS |
Ciltacabtagene Car-pos T | 36 | $553,169.30 | $1,769,194.80 | $1,161,182.05 |
nat. median $674,867 1.7× median |
|
Q2055 HCPCS |
Idecabtagene Vicleucel Car | 36 | $527,622.46 | $1,596,080.04 | $1,061,851.25 |
nat. median $625,184 1.7× median |
|
Q2054 HCPCS |
Lisocabtagene Mara Car Pos T | 36 | $516,442.29 | $1,561,076.62 | $1,038,759.45 |
nat. median $673,137 1.5× median |
|
Q2042 HCPCS |
Tisagenlecleucel Car-pos T | 36 | $572,452.94 | $1,467,605.80 | $1,020,029.37 |
nat. median $753,246 1.4× median |
|
Q2053 HCPCS |
Brexucabtagene Car Pos T | 36 | $489,399.16 | $1,419,160.56 | $954,279.86 |
nat. median $619,808 1.5× median |
|
5834 APR_DRG |
6 | $838,113.55 | $880,019.57 | $846,494.76 |
nat. median $309,665 outlier · 2.7× |
|
|
74 APR_DRG |
5 | $815,317.64 | $856,083.85 | $815,317.64 |
nat. median $187,061 outlier · 4.4× |
|
|
5833 APR_DRG |
6 | $709,683.75 | $745,168.23 | $716,780.65 |
nat. median $244,017 outlier · 2.9× |
|
|
24 APR_DRG |
5 | $682,695.67 | $716,830.74 | $682,695.67 |
nat. median $234,729 outlier · 2.9× |
|
|
5884 APR_DRG |
6 | $530,512.13 | $557,037.95 | $535,817.29 |
nat. median $246,434 outlier · 2.2× |
|
|
1614 APR_DRG |
6 | $515,163.67 | $540,922.06 | $520,315.35 |
nat. median $207,730 outlier · 2.5× |
|
|
Q2041 HCPCS |
Axicabtagene Ciloleucel Car+ | 22 | $1.73 | $1,353,617.00 | $510,290.19 |
nat. median $634,303 0.8× median |
|
94 APR_DRG |
6 | $482,627.24 | $506,758.80 | $487,453.55 |
nat. median $164,834 outlier · 3.0× |
|
|
6304 APR_DRG |
6 | $394,736.39 | $414,473.37 | $398,683.79 |
nat. median $150,721 outlier · 2.6× |
|
|
6094 APR_DRG |
6 | $391,238.32 | $410,800.40 | $395,150.73 |
nat. median $162,982 outlier · 2.4× |
|
|
5832 APR_DRG |
6 | $353,619.21 | $371,300.31 | $357,155.43 |
nat. median $156,126 outlier · 2.3× |
|
|
J9029 HCPCS |
Instill Adstiladrin, Tx Dose | 36 | $63,235.61 | $611,200.00 | $337,217.80 |
nat. median $69,774 outlier · 4.8× |
|
2004 APR_DRG |
6 | $312,036.36 | $327,638.30 | $315,156.75 |
nat. median $32,541 outlier · 9.7× |
|
|
5831 APR_DRG |
6 | $311,368.74 | $326,937.31 | $314,482.45 |
nat. median $144,745 outlier · 2.2× |
|
|
73 APR_DRG |
5 | $287,694.45 | $302,079.29 | $287,694.45 |
nat. median $89,273 outlier · 3.2× |
|
|
5883 APR_DRG |
6 | $284,655.43 | $298,888.32 | $287,502.01 |
nat. median $182,665 1.6× median |
|
|
5882 APR_DRG |
6 | $283,354.42 | $297,522.26 | $286,187.98 |
nat. median $145,336 2.0× median |
|
|
44 APR_DRG |
6 | $282,621.70 | $296,752.90 | $285,447.94 |
nat. median $105,658 outlier · 2.7× |
|
|
8414 APR_DRG |
6 | $281,406.76 | $295,477.21 | $284,220.85 |
nat. median $160,267 1.8× median |
|
|
6314 APR_DRG |
6 | $278,596.17 | $292,526.09 | $281,382.15 |
nat. median $122,924 outlier · 2.3× |
|
|
8504 APR_DRG |
6 | $271,256.85 | $284,819.80 | $273,969.44 |
nat. median $73,845 outlier · 3.7× |
|
|
5914 APR_DRG |
6 | $268,826.96 | $282,268.42 | $271,515.25 |
nat. median $164,289 1.7× median |
|
|
1613 APR_DRG |
6 | $268,510.26 | $281,935.88 | $271,195.39 |
nat. median $119,796 outlier · 2.3× |
|
|
5881 APR_DRG |
6 | $267,091.17 | $280,445.84 | $269,762.10 |
nat. median $124,573 outlier · 2.2× |
|
|
18 MS_DRG |
Chimeric Antigen Receptor (car) T-cell And Other Immunotherapies | 23 | $239,069.44 | $811,793.46 | $269,267.68 |
nat. median $370,174 0.7× median |
|
84 APR_DRG |
6 | $243,573.57 | $255,752.35 | $246,009.33 |
nat. median $79,774 outlier · 3.1× |
|
|
14 APR_DRG |
5 | $244,553.47 | $256,781.24 | $244,553.47 |
nat. median $129,535 1.9× median |
|
|
6814 APR_DRG |
6 | $239,245.68 | $251,208.06 | $241,638.15 |
nat. median $73,288 outlier · 3.3× |
|
|
1604 APR_DRG |
6 | $239,112.15 | $251,067.86 | $241,503.29 |
nat. median $97,957 outlier · 2.5× |
|
|
93 APR_DRG |
6 | $237,113.73 | $248,969.52 | $239,484.89 |
nat. median $78,990 outlier · 3.0× |
|
|
2464 APR_DRG |
6 | $231,872.15 | $243,465.85 | $234,190.89 |
nat. median $22,749 outlier · 10.3× |
|
|
6034 APR_DRG |
6 | $230,675.97 | $242,209.86 | $232,982.74 |
nat. median $109,499 outlier · 2.1× |
|
|
5891 APR_DRG |
6 | $223,846.46 | $235,038.87 | $226,084.95 |
nat. median $93,370 outlier · 2.4× |
|
|
5934 APR_DRG |
6 | $223,176.64 | $234,335.56 | $225,408.42 |
nat. median $151,838 1.5× median |
|
|
64 APR_DRG |
5 | $223,864.12 | $235,057.41 | $223,864.12 |
nat. median $91,009 outlier · 2.5× |
|
|
5892 APR_DRG |
6 | $216,952.95 | $227,800.69 | $219,122.50 |
nat. median $89,796 outlier · 2.4× |
|
|
1624 APR_DRG |
6 | $208,585.18 | $219,014.52 | $210,671.05 |
nat. median $81,781 outlier · 2.6× |
|
|
6024 APR_DRG |
6 | $205,162.15 | $215,420.34 | $207,213.79 |
nat. median $118,620 1.7× median |
Other procedures at this hospital
Browse this hospital's 19,292 published procedures. Use the slice to choose what to show, then sort or filter any column.